Evidence mounts on safety of RAS blockade in COVID-19

A meta-analysis provides ‘solid evidence’ that common antihypertensives do not worsen outcomes, researchers say

Most people with hypertension will be safe to stay on their renin-angiotensin system (RAS) blockers if they develop COVID-19, according to a meta-analysis.

senior man in mask having his BP taken by a nurse

Italian researchers pooled data from 10 observational studies to see whether people on the antihypertensives were more at risk of severe or fatal COVID-19 than patients with hypertension who were not taking the drugs.

The meta-analysis included data from nearly 10,000 patients with